MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。

Cemsidomide

CAS No. : 2504235-67-8

產(chǎn)品活性：Cemsidomide (CFT7455) is an orally active zinc finger transcription factors Ikaros (IKZF1), Aiolos (IKZF3) degrader. Cemsidomide is an anti-cancer agent that binds with high affinity to the cereblon E3 ligase (K_d of 0.9 nM) (WO2022032132A1; Compound 1).

研究領(lǐng)域：PROTAC

作用靶點(diǎn)：Ligands for E3 Ligase

In Vitro: Cemsidomide promotes the degradation of >75% of steady state IKZF1 in multiple myeloma cells within 1.5 hours at 0.3 nM. The high binding affinity and degradation catalysis of CFT7455 enables potent cell growth inhibition in both previously untreated NCIH929 multiple myeloma cell lines (IC₅₀ of 0.071 nM) and NCIH929 cells made resistant to both lenalidomide and pomalidomide (IC₅₀ of 2.3 nM).
Cemsidomide has potent antiproliferative activity against multiple myeloma cells and IMiD-resistant H929 cells.

In Vivo: In mouse xenograft tumor models, Cemsidomide demonstrates dose dependent efficacy from 3 μg/kg/day to 100 μg/kg/day. In several tumor xenografts tested daily dosing of Cemsidomide at dose of 30 μg/kg/day to 100 μg/kg/day led to durable tumor regression.
Cemsidomide (0.1 mg/kg/day; for 21 days) promotes tumor regression in the H929 tumor xenograft model (95% tumor growth inhibition by 7 days).

相關(guān)產(chǎn)品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Ubiquitination Compound Library  |  Orally Active Compound Library  |  Anti-Blood Cancer Compound Library  |  Transcription Factor-Targeted Library  |  E3 Ligase Ligand Library  |  Heterocyclic Compound Library  |  Lenalidomide hydrochloride  |  Thalidomide-NH-CH2-COOH  |  Pomalidomide-d₃  |  Thalidomide-5-propoxyethanamine  |  Pomalidomide-5-O-CH3  |  BODIPY FL thalidomide  |  VH032-OH  |  TD-106  |  SJPYT-195  |  Lenalidomide-5-aminomethyl hydrochloride  |  BC-1215  |  Thalidomide-5-propargyne-NH2 hydrochloride  |  Thalidomide 5-fluoride  |  VH032 thiol  |  Lenalidomide-5-Br  |  CRBN modulator-1  |  E3 ligase Ligand 21  |  Pomalidomide-C5-Dovitinib  |  Lenalidomide-6-F  |  E3 ligase Ligand 8  |  LCL-PEG3-N3 hydrochloride  |  Thalidomide-5-PEG2-Cl  |  Golcadomide  |  Thalidomide-O-C8-COOH  |  CC-885  |  ALV2  |  Thalidomide-5-methyl  |  E3 ligase Ligand 13  |  Pomalidomide-C11-NH2

熱門產(chǎn)品線：重組蛋白  |  化合物庫(kù)  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物  |  寡核苷酸  |  抗體  |  點(diǎn)擊化學(xué)

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種*僅有化合物庫(kù)，我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng)；
•   產(chǎn)品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產(chǎn)品，廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目；
•   提供虛擬篩選，離子通道篩選，代謝組學(xué)分析檢測(cè)分析，藥物篩選等專業(yè)技術(shù)服務(wù)；
•   設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告，確保產(chǎn)品的高純度、高品質(zhì)；
•   產(chǎn)品的生物活性多經(jīng)各國(guó)客戶實(shí)驗(yàn)驗(yàn)證；
•   Nature, Cell, Science 等多種頂級(jí)期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業(yè)團(tuán)隊(duì)跟蹤新的制藥及生命科學(xué)研究進(jìn)展，為您提供*新的活性化合物；
•   與世界各大制藥公司及*科研機(jī)構(gòu)建立了長(zhǎng)期的合作。